Back
Structure Therapeutics Stock Price Chart
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Sell
30
GPCR
Structure Therapeutics
Last Price:
37.44
Seasonality Move:
-29.59%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight selling pressure.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.24 | Sell |
| 20-day SMA: | 40.3 | Sell |
| 50-day SMA: | 39.44 | Sell |
| 200-day SMA: | 40.54 | Sell |
| 8-day EMA: | 38.81 | Sell |
| 20-day EMA: | 39.47 | Sell |
| 50-day EMA: | 39.57 | Sell |
| 200-day EMA: | 39.79 | Sell |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 44.56 | Sell |
| Chaikin Money Flow: | -194701 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.28 - 42.62) | Sell |
| Bollinger Bands (100): | (35.56 - 45.66) | Sell |
Structure Therapeutics Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 38.07 while GPCR 8-day simple moving average is 38.24, which is a Sell signal.
- The stock price of GPCR is 38.07 while Structure Therapeutics 20-day SMA is 40.30, which makes it a Sell.
- Structure Therapeutics 50-day simple moving average is 39.44 while GPCR share price is 38.07, making it a Sell technically.
- GPCR stock price is 38.07 and Structure Therapeutics 200-day simple moving average is 40.54, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
30
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a Sell
The current Structure Therapeutics [GPCR] share price is $38.07. The Score for GPCR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
2.18B
Price in USD:
38.07
Share Volume:
534.3K
Structure Therapeutics 52-Week Range
52-Week High:
75.02
52-Week Low:
26.61
Sell
30
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?
The Structure Therapeutics stock price is 38.07 USD today. -
Will GPCR stock go up or go down?
Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Structure Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 38.07 while GPCR 8-day exponential moving average is 38.81, which is a Sell signal.
- The stock price of GPCR is 38.07 while Structure Therapeutics 20-day EMA is 39.47, which makes it a Sell.
- Structure Therapeutics 50-day exponential moving average is 39.57 while GPCR share price is 38.07, making it a Sell technically.
- GPCR stock price is 38.07 and Structure Therapeutics 200-day simple moving average is 39.79, creating a Sell signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
- GPCR Moving Average Covergence Divergence (MACD) indicator is -0.45, suggesting Structure Therapeutics is a Sell
- Structure Therapeutics Relative Strength Index (RSI) is 44.56, which suggest Structure Therapeutics is oversold
- The Bollinger Bands (25) for Structure Therapeutics is (38.28 - 42.62), which suggest Structure Therapeutics is a Sell
- The Bollinger Bands (100) for Structure Therapeutics is (35.56 - 45.66), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.